PTPRC and neoplasm: Interestingly, in the 4T1 tumor model, AIMS(EPT, R848, PTX) treatment increased PD‐L1 expression in CD45− cells, whereas there was no significant increase in PD‐1 expression in CD3+ cells (Figure 8c,d; Figure S18a, Supporting Information).